ENCell Co., Ltd. (KOSDAQ:456070)
South Korea flag South Korea · Delayed Price · Currency is KRW
16,280
-180 (-1.09%)
Apr 29, 2026, 3:30 PM KST

ENCell Revenue

In the year 2025, ENCell had annual revenue of 5.26B KRW, down -27.06%. ENCell had revenue of 1.44B in the quarter ending December 31, 2025, a decrease of -31.07%.

Revenue
5.26B
Revenue Growth
-27.06%
P/S Ratio
34.44
Revenue / Employee
n/a
Employees
n/a
Market Cap
181.08B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20255.26B-1.95B-27.06%
Dec 31, 20247.21B-3.32B-31.51%
Dec 31, 202310.53B3.16B42.87%
Dec 31, 20227.37B3.46B88.49%
Dec 31, 20213.91B2.50B178.37%
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Macrogen 195.27B
Vaxcell-Bio Therapeutics 1.90B
MedPacto 3.90B
Amicogen 41.98B
Genexine 5.81B
JETEMA, 76.90B
EASY BIO,Inc. 476.94B
iNtRON Biotechnology 5.74B
Revenue Rankings